ArticleJournal of internal medicine2017

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

H K G Garelius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.